Chronic exposure to high glucose concentrations increases proglucagon messenger ribonucleic acid levels and glucagon release from InR1G9 cells
- PMID: 10499521
- DOI: 10.1210/endo.140.10.7052
Chronic exposure to high glucose concentrations increases proglucagon messenger ribonucleic acid levels and glucagon release from InR1G9 cells
Abstract
Alpha cell function is impaired in diabetes. In diabetics, plasma levels of glucagon are high despite persistently elevated glucose levels and may even rise paradoxically in response to a glucose load; high plasma glucagon levels are accompanied by increased proglucagon gene expression. We have investigated the effects of high glucose concentrations on InR1G9 cells, a glucagon-producing cell line. We show here that chronically elevated glucose concentrations increase glucagon release by 2.5- to 4-fold, glucagon cell content by 2.5- to 3-fold, and proglucagon messenger RNA levels by 4- to 8-fold, whereas changes for 24 h have no effect on proglucagon messenger RNA levels. Persistently elevated glucose affects proglucagon gene expression at the level of transcription and insulin is capable of preventing this effect. We conclude that chronically elevated glucose may be an important factor in the alpha cell dysfunction that occurs in diabetes and thus that glucose may not only affect the beta cell but also the alpha cell.
Similar articles
-
Glucose regulates proinsulin and prosomatostatin but not proglucagon messenger ribonucleic acid levels in rat pancreatic islets.Endocrinology. 2000 Jan;141(1):174-80. doi: 10.1210/endo.141.1.7230. Endocrinology. 2000. PMID: 10614637
-
Insulin, but not glucose lowering corrects the hyperglucagonemia and increased proglucagon messenger ribonucleic acid levels observed in insulinopenic diabetes.Endocrinology. 1998 Nov;139(11):4540-6. doi: 10.1210/endo.139.11.6294. Endocrinology. 1998. PMID: 9794463
-
Glucagon gene 3'-flanking sequences direct formation of proglucagon messenger RNA 3'-ends in islet and nonislet cells lines.Mol Endocrinol. 1990 Jun;4(6):800-6. doi: 10.1210/mend-4-6-800. Mol Endocrinol. 1990. PMID: 2233738
-
Proglucagon-derived peptides in the neuroendocrine system.Adv Exp Med Biol. 1991;291:143-59. doi: 10.1007/978-1-4684-5931-9_12. Adv Exp Med Biol. 1991. PMID: 1927680 Review.
-
Molecular pathophysiology of glucagon-SV40 T antigen transgenic mice.Am J Physiol. 1994 Nov;267(5 Pt 1):E629-35. doi: 10.1152/ajpendo.1994.267.5.E629. Am J Physiol. 1994. PMID: 7977712 Review.
Cited by
-
Glucotoxicity induces abnormal glucagon secretion through impaired insulin signaling in InR1G cells.PLoS One. 2017 Apr 20;12(4):e0176271. doi: 10.1371/journal.pone.0176271. eCollection 2017. PLoS One. 2017. PMID: 28426798 Free PMC article.
-
Human Glucagon Expression Is under the Control of miR-320a.Endocrinology. 2021 Mar 1;162(3):bqaa238. doi: 10.1210/endocr/bqaa238. Endocrinology. 2021. PMID: 33367814 Free PMC article.
-
Intercellular Communication in the Islet of Langerhans in Health and Disease.Compr Physiol. 2021 Jun 30;11(3):2191-2225. doi: 10.1002/cphy.c200026. Compr Physiol. 2021. PMID: 34190340 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources